Poster

Perioperative chemotherapy for operable gastro-esophageal or gastric cancer: Anthracycline triplets versus FLOT

BackgroundThe MAGIC trial (2006) showed improved survival of patients with gastric or gastro-esophageal junction (GEJ) carcinoma treated with perioperative chemotherapy (epirubicin, cispl...

06/25/2023

The prognostic ability of immunoscore in predicting outcomes in patients with localized colon cancer: A systematic review and meta-analysis

BackgroundAssessment of tumor recurrence risk as well as prognosis in resectable colon cancer are still mainly based on the histopathological criteria of tumor invasion reflected in the T...

06/25/2023

Gastric cancer metastasis patterns and racial disparities: SEER database population study 2010-2019

BackgroundMetastasis is a poor prognostic factor for gastric cancer. Disparities between African-Americans and Caucasians in metastasis patterns require further investigation. Thus, this ...

06/25/2023

RAS/ BRAF molecular profile in metastatic versus non-metastatic colorectal cancer

BackgroundRAS and BRAF genes are crucial therapeutic and prognostic markers in metastatic colorectal cancer. Once activated, these oncogenes play a key role in colorectal carcinogenesis f...

06/25/2023

Single institute experience of peri-operative FLOT chemotherapy

BackgroundPatients with locally advanced gastric or gastroesophageal junction adenocarcinoma (LAGC) usually presents with significant loss of weight and appetite affecting their overall p...

V. Bansal ;

J. Morris ;

Ruby Roy ;

06/25/2023

ARID1A as a prognostic biomarker in gastroesophageal cancer: A genomic database analysis

BackgroundIn recent years, a steady increase of genomic studies has contributed to reveal the complex molecular landscape of Gastroesophageal Adenocarcinoma (GEA), shedding new light on n...

06/25/2023

Real-world survival outcome in gastric cancer in a resource limited setting – an Indian experience

BackgroundGastric cancer is a less often talked about but a largely prevalent malignancy in India. According to the Globocan 2020 data, mortality due to gastric cancer has reduced and is ...

06/25/2023

Management of EaRly-onset MetastatIc cOlorectal caNcEr (ERMIONE): A single institution analysis

BackgroundDespite rising incidence and mortality reported worldwide for CRC diagnosed in pts aged < 50 yrs, currently early onset metastatic CRC (EOmCRC) are treated as their older cou...

06/25/2023

RAS/RAF mutation status in Algerian patients with metastatic colorectal cancer (mCRC) and impact of the primary site on clinical and prognostic outcomes

BackgroundRAS/RAF mutation status is a major molecular outcome in colorectal cancer (CRC), and these mutations have been suggested as predictive and prognostic biomarkers. Previous report...

06/25/2023

Analysis of microsatellite and RAS/RAF status in Tunisian colorectal cancer series

BackgroundTherapeutic strategies for colo-rectal relies on several parameters among which microsatellite (MS) and RAS/RAF status have important value. The aim of our study was to analyze ...

06/25/2023